Boston Scientific’s Post

Pulsed field ablation is a cutting-edge technology to treat atrial fibrillation – yet it’s expected to be adopted so quickly that by 2028 it may account for more than 60% of all #AFib procedures. Read in The Wall Street Journal why the worldwide medical community is excited about this transformative technology: https://lnkd.in/gJ3q7sXd

Women and people of color are severely underrepresented in clinical trial research. That’s a problem, because without their inclusion in clinical trials, it’s harder to know how well medical treatments will work for them. Learn how we're working to improve these numbers. #MinorityHealthMonth https://bit.ly/4aqnu9z

When Camille Chang Gilmore, MBA’s mother developed terrible leg pain, it took several weeks and three doctors until she was finally diagnosed with a heart attack. “No one should struggle to get critical care the way my mother did,” writes Camille, VP Human Resources, Global Chief Diversity, Equity and Inclusion Officer. For National Minority Health month, read her powerful op-ed about health disparities for women and people of color, and how our Close the Gap initiative helps health systems take meaningful steps toward greater equity: https://bit.ly/4aEPead

From providing employees with a range of inclusive benefits, to educating physicians about caring for LGBTQ+ patients, we are committed to championing equity, diversity and openness. In honor of Transgender Day of Visibility, learn more about how we show our support: https://bit.ly/43FIOVX

We have been named a 2024 Most Innovative Company by Fortune! Learn more about our efforts to become a top innovator: https://bit.ly/3vxOCUT

Endoluminal surgery (ELS) is incision-free, scarless, and is being hailed as the next generation of surgery. In the newest episode of our Boston Scientific Talks podcast, Brian Dunkin, Chief Medical Officer of Endoscopy, and Mike Jones, Endoscopy President and SVP, discuss how the ELS products from our Apollo Endosurgery acquisition represent a step forward in GI care, including for the treatment of obesity: https://bit.ly/3vgzGKN

We strive to ensure all of our employees have equitable opportunities to grow and advance in their careers. Three women in leadership roles around the globe share how the company, and its culture, have encouraged them to thrive. https://bit.ly/3VkqSOJ

Pain affects more than 30% of people around the globe. As Relievant Medsystems, Inc. officially becomes part of Boston Scientific, Jim Cassidy, president, Neuromodulation, shares his thoughts on how the acquisition stands to benefit patients living with chronic pain. https://bit.ly/3TeE3hq